ガドクアトランの世界市場規模、シェア、成長分析、用途別、エンドユーザー別 - 産業予測、2024～2031年

世界のガドクアトランの市場規模は、2022年に18億4,000万米ドルとなり、予測期間（2024～2031年）のCAGRは5.28%で、2023年の19億4,000万米ドルから、2031年までには29億2,000万米ドルに成長する見通しです。

磁気共鳴画像法（MRI）用造影剤は、MRI検査で得られる画像の質を向上させるために使用されます。これらの薬剤は、スキャンされる組織の磁気特性を変化させ、健康な組織と病気の組織の区別を可能にします。四量体ガドクアトランは、磁気共鳴イメージングに使用される新規で非常に効果的なmGBCAです。ガドクアトランは、望ましい物理化学的特性（高い緩和性と安定性、低タンパク質結合）と、市販されている一般的なmGBCAとほぼ同じPKプロファイル（迅速な細胞外分布、無傷の状態での腎臓を介した迅速な排泄）を示します。今後数年間は、診断や治療計画のために画像診断を必要とするがん、神経疾患、心血管疾患などの慢性疾患の頻度が高まるため、MRI造影剤のニーズが大幅に増加する可能性が高いです。また、高齢化の進展や非侵襲的な診断治療に対するニーズの高まりも、市場拡大を後押しすると予想されます。

目次

エグゼクティブサマリー

• 市場概要
• 運命の輪

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要な市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主要な投資の分析
• 主要な成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

ガドクアトランの世界市場：用途別

• 市場概要
• スクリーニング・診断

ガドクアトランの世界市場：エンドユーザー別

• 市場概要
• 病院
• 診断センター
• 専門クリニック
• その他

ガドクアトランの世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Bayer AG

Global Gadoquatrane Market was valued at USD 1.84 Billion in 2022 and is poised to grow from USD 1.94 Billion in 2023 to USD 2.92 Billion by 2031, at a CAGR of 5.28% during the forecast period (2024-2031).

Contrast media agents for magnetic resonance imaging (MRI) are used to improve the quality of pictures obtained during an MRI scan. These medications alter the magnetic properties of the tissue being scanned, allowing for the distinction between healthy and ill tissues. Tetrameric gadoquatrane is a novel, highly effective mGBCA for use in magnetic resonance imaging. Desirable physicochemical properties (high relaxivity and stability, low protein binding) and a nearly identical PK profile to popular mGBCAs on the market (rapid extracellular distribution, quick excretion via the kidneys in an intact state) are displayed by gadoquatrane. In the upcoming years, there will likely be a large increase in the need for MRI contrast media agents due to the rising frequency of chronic illnesses like cancer, neurological disorders, and cardiovascular diseases, all of which need imaging for diagnosis and treatment planning. Further propelling the market expansion are anticipated to be the aging population and the rising need for non-invasive diagnostic treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gadoquatrane Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gadoquatrane Market Segmental Analysis

Global Gadoquatrane Market is segmented based on Applications, End User, and region. Based on End User, the market is segmented into Hospital, Imaging Centers. Based on region the global Gadoquatrane Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Gadoquatrane Market

Chronic diseases like cancer, cardiovascular disease, and neurological problems are becoming more common, which is driving up the need for MRI scans for diagnosis and treatment planning. Contrast chemicals are used to increase the quality of these images and make it easier for medical professionals to identify irregularities. Additionally, as the global population ages, older people are more likely to have chronic illnesses, necessitating more regular diagnostic imaging. Consequently, there is a rise in the need for contrast agents and MRI scans. Furthermore, there is no need for surgery or other intrusive procedures because MRI is a non-invasive diagnostic method. The market is expanding due to the growing demand for MRI scans and contrast media agents as more patients look for non-invasive diagnostic options. Furthermore, advances in MRI technology have made it possible to produce higher-quality pictures, which can be enhanced even further with the addition of contrast media agents. As a result, there is now a greater need for these medications in both clinical and research settings. Additionally, greater funding is being allocated by governments and private healthcare institutions to the infrastructure of the healthcare sector, which includes advanced imaging technologies like magnetic resonance imaging (MRI). The increased accessibility of MRI scans and contrast media for patients is driving up demand for these products.

Restraints in the Global Gadoquatrane Market

MRI contrast media agents may become less expensive due to a variety of factors that limit demand. Among these reasons include cost, safety issues, the advent of alternative diagnostic methods, and the shift to value-based treatment. Furthermore, the development of non-contrast MRI methods might make market growth more difficult. As a result of technological developments, less contrast agents are needed for non-contrast MRI treatments, which are becoming more accurate and efficient. Furthermore, as MRI contrast agents can be costly, some patients and medical professionals may decide to forego contrast in favor of non-contrast MRI techniques in order to save money in light of the growing cost of healthcare. Additionally, there have been a few reported cases of unfavorable side effects, such as allergic responses and nephrogenic systemic fibrosis (NSF), even though MRI contrast agents are generally thought to be harmless. As awareness of these risks grows, some people and medical professionals may choose to completely avoid using contrast agents. Furthermore, value-based care-which emphasizes delivering high-quality treatment while reducing costs-is being emphasized by healthcare providers more and more. This could lead to a decreased need for pricey contrast agents. Additionally, there are situations where ultrasonography or CT scans can be used instead of MRIs, which further minimizes the requirement for MRI contrast agents.

Market Trends of the Global Gadoquatrane Market

Contrast drugs based on gadolinium have been associated with uncommon but dangerous side effects, especially in those with kidney disease. Consequently, there's been a growing interest in creating gadolinium-free contrast agents, like manganese-based agents and iron oxide nanoparticles.

The goal of research is to create contrast agents that can target particular bodily tissues or cells. This may make it possible to obtain more accurate imaging and provide better illness diagnosis and therapy.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Gadoquatrane Market by Applications

• Market Overview
• Screening and Diagnosis

Global Gadoquatrane Market by End User

• Market Overview
• Hospital
• Diagnostic Centres
• Specialty Clinics
• Others

Global Gadoquatrane Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments